In our study, we observed that iPSCs alone increased the frequency of IL-17+CD4+ Th17 cells in TDLNs compared with PBS control, whereas the C + I vaccine significantly decreased the relative frequency of these cells compared with the iPSCs alone group, and reversed the tumor-promoting immune environment (Figure 3D). Here, IL17A is linked to neoplasm.